Medicinal Products

Deferasiroks Pliva 250 mg tablete za oralnu suspenziju

Name Deferasiroks Pliva 250 mg tablete za oralnu suspenziju
Marketing Authorisation Number HR-H-971006372
Active Substance deferasiroxum
Pharmaceutical Form tableta za oralnu suspenziju
Strength 250 mg
Packaging [MA Number for Packaging] 28 tableta u blisteru, u kutiji  [HR-H-971006372-01]
28x1 tableta u perforiranom blisteru s jediničnom dozom, u kutiji  [HR-H-971006372-02]
30 tableta u blisteru, u kutiji  [HR-H-971006372-03]
30x1 tableta u perforiranom blisteru s jediničnom dozom, u kutiji  [HR-H-971006372-04]
84 tablete u blisteru, u kutiji  [HR-H-971006372-05]
84x1 tableta u perforiranom blisteru s jediničnom dozom, u kutiji  [HR-H-971006372-06]
98 tableta u blisteru, u kutiji  [HR-H-971006372-07]
98x1 tableta u perforiranom blisteru s jediničnom dozom, u kutiji  [HR-H-971006372-08]
Manufacturer Teva UK Ltd., Eastbourne, Ujedinjeno Kraljevstvo;
Pliva Hrvatska d.o.o., Zagreb, Republika Hrvatska;
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb
Marketing Authorisation Date 22.09.2017
MA Period of Validity 22.09.2022
Classification Number UP/I-530-09/16-01/185
Registration Number 381-12-01/30-17-08
Composition svaka tableta za oralnu suspenziju sadrži 250 mg deferasiroksa
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code V03AC03
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 2
Back